In a move signaling both the technical complexity of modern global health governance and the persistent urgency of pandemic preparedness, Member States of the World Health Organization (WHO) have concluded the latest session of the Intergovernmental Working Group (IGWG) with a strategic decision: more time is required to finalize the Pathogen Access and Benefit Sharing (PABS) system.
While the PABS annex remains the "final piece of the puzzle" for the landmark WHO Pandemic Agreement, delegates meeting in Geneva have agreed to push the deadline for its completion further into the future. This decision reflects the delicate balancing act between rapid scientific data sharing and the equitable distribution of life-saving medical countermeasures—a tension that defined the failures of the international response during the COVID-19 pandemic.
The Core Mandate: What is the PABS System?
At its heart, the PABS system is an ambitious mechanism designed to rewrite the rules of engagement for international public health emergencies. The system rests on two interdependent pillars:
- Rapid Pathogen Access: Ensuring that as soon as a pathogen with pandemic potential is identified anywhere in the world, its genetic sequence and biological data are shared immediately with the global scientific community to facilitate research.
- Equitable Benefit Sharing: Ensuring that the fruits of that research—specifically vaccines, diagnostics, and therapeutics—are shared fairly and equitably among all nations, regardless of their economic status or manufacturing capacity.
During the height of the COVID-19 pandemic, the world witnessed a "vaccine apartheid," where high-income nations secured the vast majority of initial doses, leaving the Global South to wait months, or even years, for access. The PABS system is the institutional answer to that inequality, seeking to codify a "quid pro quo" arrangement where countries that contribute data receive guaranteed, affordable access to the resulting medical products.
A Chronology of Negotiations: From Adoption to Extension
The journey toward the PABS system began in earnest following the lessons of 2020. The timeline of this diplomatic effort highlights the sheer scale of the task:
- May 2025: The World Health Assembly (WHA) officially adopts the WHO Pandemic Agreement, a historic commitment to fortify global health security. The agreement establishes an open-ended Intergovernmental Working Group (IGWG) tasked specifically with drafting the PABS framework.
- Late 2025 – Early 2026: The IGWG conducts a series of intense, closed-door negotiations in Geneva. Experts in international law, epidemiology, and trade policy grapple with the legal language required to make benefit-sharing a binding obligation rather than a voluntary guideline.
- May 2026 (Current Status): The sixth meeting of the IGWG concludes. While significant progress is noted in the technical drafting, Member States acknowledge that key sticking points regarding intellectual property, patent waivers, and supply chain commitments remain unresolved.
- May 2026 (Forthcoming): The outcome of the sixth session is to be presented to the 79th World Health Assembly. The Assembly is expected to pass a resolution granting the IGWG an extension, pushing the finalization deadline to 2027, with a potential interim special session in 2026.
- July 2026: The seventh session of the IGWG is scheduled to commence, marking the start of this extended negotiation phase.
The Stakes: Why "When, Not If" Defines the Discourse
Dr. Tedros Adhanom Ghebreyesus, Director-General of the WHO, has been vocal about the necessity of this work. His mantra—that the next pandemic is a matter of "when, not if"—serves as the backdrop for all IGWG discussions.
"The PABS annex is the last piece of the puzzle," Dr. Tedros noted following the latest session. "Not only for the Pandemic Agreement but for all the initiatives that WHO and Member States have implemented as a result of lessons learned from the COVID-19 pandemic."
The urgency stems from a sobering reality: the global health architecture is currently built on a foundation of voluntary cooperation. When a new, highly transmissible virus emerges, countries are often incentivized to prioritize their own citizens first, leading to the hoarding of supplies and the fragmentation of global data. The PABS system aims to institutionalize solidarity, ensuring that national self-interest does not come at the expense of global security.
Perspectives from the Negotiating Table: Official Responses
The complexity of the task cannot be overstated. Drafting a legal instrument that binds 194 Member States to specific protocols regarding biological data and commercial intellectual property requires navigating a minefield of national interests.
Ambassador Tovar da Silva Nunes of Brazil, serving as the IGWG Bureau Co-Chair, emphasized the need for precision. "Finalizing a document of such technical and legal complexity requires precision and dedication," he stated. "We are not there yet, but with an extension of our negotiations, we will get there."
His sentiments were echoed by his co-chair, Mr. Matthew Harpur. "WHO Member States have demonstrated strong and continuing commitment to negotiations… We are moving in the right direction to finalize the PABS annex, and in doing so provide the WHO Pandemic Agreement with the framework needed to ensure countries are better, and more equitably, prepared."
Despite the optimistic tone of the leadership, observers suggest that the primary friction points involve the private sector’s role. Pharmaceutical companies, which are responsible for the R&D of many countermeasures, have expressed concerns regarding how the PABS system might impact their intellectual property rights. Finding a middle ground that satisfies the demands for equity while maintaining the incentives for innovation is the "hard labor" currently being performed by the IGWG.
Implications for Global Health Architecture
The failure to finalize the PABS annex in this session does not signify a failure of the agreement itself, but rather an acknowledgement of the high stakes involved. The implications of this work are profound:
1. Strengthening International Law
If successfully ratified, the PABS annex will represent one of the most significant expansions of international health law in decades. It transforms "benefit sharing" from a buzzword into a concrete, legally enforceable obligation.
2. Bridging the North-South Divide
The PABS system is effectively a mechanism for technology transfer. By ensuring that pathogens shared by countries in the Global South lead to tangible medical benefits, the system seeks to rectify the historical imbalance that has left developing nations vulnerable during previous outbreaks.
3. Economic and Trade Disruptions
The negotiation process is also a massive economic exercise. Governments are debating how to manage the global supply chain for vaccines during a crisis. This includes discussions on "pre-purchase agreements," "tiered pricing," and "mandatory technology transfers," all of which directly impact the profit margins of the global pharmaceutical industry.
4. Setting a Precedent for Future Crises
The framework developed here will likely serve as the blueprint for future international responses to other global threats, including antimicrobial resistance (AMR) and climate-related health challenges.
Looking Ahead: The Road to 2027
As the IGWG prepares for its seventh meeting in July 2026, the global health community remains in a state of watchful waiting. The extension of the timeline—potentially stretching into 2027—may frustrate those who advocate for immediate action, but it offers a pragmatic path forward.
The challenge for the next year of negotiations will be to move beyond the high-level principles of "equity" and "sharing" and into the granular, technical details of implementation. This includes defining exactly what constitutes "pandemic potential," determining the mechanisms for triggering the benefit-sharing clauses, and establishing the oversight bodies that will ensure compliance.
In the final analysis, the PABS system is an admission that the world is interconnected. The health of a nation is no longer a purely domestic affair; in an age of rapid transit and global trade, a pathogen anywhere is a threat everywhere. By committing to this protracted and difficult negotiation process, WHO Member States are acknowledging that while the next pandemic is inevitable, the scale of the tragedy it brings is not.
The coming months will test whether the international community has the political will to sacrifice short-term national interests for long-term global stability. As the IGWG Bureau prepares for the next round of talks, the world looks on, hopeful that the "final piece of the puzzle" will soon be put in place, creating a more secure and equitable future for all.
About the Author
